Arcturus Therapeutics Holdings, Inc. (ARCT)
7.125
-0.18
(-2.40%)
USD |
NASDAQ |
Jun 08, 16:00
7.125
0.00 (0.00%)
After-Hours: 18:30
Arcturus Therapeutics Holdings Profit Margin (Quarterly) : -4.42K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Ionis Pharmaceuticals, Inc. | -37.60% |
| Oncotelic Therapeutics, Inc. | -- |
| Enanta Pharmaceuticals, Inc. | -76.29% |
| Veracyte, Inc. | 20.64% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.93% |
| Return on Assets | -27.32% |
| Return on Invested Capital | -31.74% |
| Gross Profit Margin (Quarterly) | -7.87% |
| Operating Margin (Quarterly) | -4.88K% |
| Return on Net Operating Assets | -197.0% |